Submissions could include data on the selected drugs, therapeutic alternatives to the selected drugs, data related to unmet medical need and impacts on specific populations as well as the patient/caregiver experience.įor further information about the Listening Sessions please contact CMS by email at with the subject line “Patient-Focused Listening Sessions.Once you’ve been prescribed DUPIXENT, your healthcare provider can download the enrollment form, help you fill it out, and fax it back to DUPIXENT MyWay at 1-84. In addition to the opportunity to provide input during a listening session, the public was also able to submit written input between September 1 – October 2, 2023, in response to the 2023 CMS information collection request about selected drugs and evidence about alternative treatments. Any other information about the selected drug, the condition(s) it is used to treat, and other treatments used for that condition(s) that the speaker believes is important. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |